Published in BMC Musculoskelet Disord on November 06, 2001
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Antiresorptive therapies for osteoporosis: a clinical overview. Nat Rev Endocrinol (2011) 1.04
Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event. BMC Med Res Methodol (2012) 1.01
Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk. Osteoporos Int (2009) 0.92
The effect of soy isoflavone on bone mineral density in postmenopausal Taiwanese women with bone loss: a 2-year randomized double-blind placebo-controlled study. Osteoporos Int (2011) 0.89
Management of age-related osteoporosis and prevention of associated fractures. Ther Clin Risk Manag (2006) 0.83
Osteoporosis. Postgrad Med J (2002) 0.82
The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men. J Osteoporos (2011) 0.80
Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study. Br J Clin Pharmacol (2007) 0.80
The prevention of postmenopausal osteoporotic fractures: results of the Health Technology Assessment of a new antiosteoporotic drug. Biomed Res Int (2014) 0.78
The effects of soy isoflavone on bone density in north region of climacteric Chinese women. J Clin Biochem Nutr (2013) 0.77
Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review. Int J Womens Health (2010) 0.77
Estrogen treatment does not reduce fractures? Menopause (2014) 0.75
Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med (2001) 9.57
Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA (2001) 5.09
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med (2000) 4.84
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
Events per person year--a dubious concept. BMJ (1995) 2.65
Prevention of spinal osteoporosis in oophorectomised women. Lancet (1980) 2.34
Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial. Ann Intern Med (1999) 2.01
Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab (2001) 1.56
Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med (2001) 1.51
A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis. Am J Med (1998) 1.04
The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial. Ann Intern Med (1999) 1.01
Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas (2000) 1.00
Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study. J Clin Endocrinol Metab (1999) 0.90
A combination of low doses of 17 beta-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women. Osteoporos Int (2000) 0.79
Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA (2001) 5.09
Systematic review of topical treatments for fungal infections of the skin and nails of the feet. BMJ (1999) 1.70
Extracts from "Clinical evidence": Athlete's foot and fungally infected toenails. BMJ (2001) 1.41
Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev (2000) 1.12
HRT and its impact on the menopause, osteoporosis and breast cancer. Expert Opin Pharmacother (2000) 0.78
Fungal infections of skin and nails of feet. Authors of meta-analysis defend their view. BMJ (1999) 0.75